Works about CHECKPOINT kinase 1

Results: 158

Predicting breast cancer prognosis based on a novel pathomics model through CHEK1 expression analysis using machine learning algorithms.

Published in:

PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0321717

By:

Chen, Chen;
Gao, Dan;
Yue, Huan;
Wang, Huijing;
Qu, Rui;
Hu, Xiaochi;
Luo, Libo

Publication type:

Article

Correction: Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.

Published in:: Biochemical Journal, 2025, v. 482, n. 7, p. 359, doi. 10.1042/BJ20021284_COR
Publication type:: Article

STAU2 protein level is controlled by caspases and the CHK1 pathway and regulates cell cycle progression in the non-transformed hTERT-RPE1 cells.

Published in:

BMC Molecular & Cell Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12860-021-00352-y

By:

Condé, Lionel;
Gonzalez Quesada, Yulemi;
Bonnet-Magnaval, Florence;
Beaujois, Rémy;
DesGroseillers, Luc

Publication type:

Article

CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02040-0

By:

Acharya, Ganesh;
Mani, Chinnadurai;
Sah, Naresh;
Saamarthy, Karunakar;
Young, Robert;
Reedy, Mark B.;
Sobol, Robert W.;
Palle, Komaraiah

Publication type:

Article

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1.

Published in:

Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01611-x

By:

Li, Lemin;
Wang, Linchen;
Liu, Dian;
Zhao, Yongchao

Publication type:

Article

Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 12, p. 915, doi. 10.20892/j.issn.2095-3941.2023.0260

By:

Qin Tang;
Xin Wang;
Haixia Wang;
Lin Zhong;
Dongling Zou

Publication type:

Article

Liquid-liquid phase separation in DNA double-strand break repair.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 9, p. 627, doi. 10.20892/j.issn.2095-3941.2023.0252

By:

Jia Chen;
Jie Shi;
Jian Zheng;
Yunlong Wang;
Xiangbo Wan

Publication type:

Article

Deletion of Non-histidine Domains of Histidine Kinase CHK1 Diminishes the Infectivity of Candida albicans in an Oral Mucosal Model.

Published in:

Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.855651

By:

Feng, Yahui;
Bian, Shaodong;
Pang, Zhiping;
Wen, Yiyang;
Calderone, Richard;
Li, Dongmei;
Shi, Dongmei

Publication type:

Article

Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells.

Published in:

Cancer Research & Treatment, 2021, v. 53, n. 3, p. 819, doi. 10.4143/crt.2020.1013

By:

Hye-yon Cho;
Yong-Beom Kim;
Wook-ha Park;
Jae Hong No

Publication type:

Article

Histone H3 serine-57 is a CHK1 substrate whose phosphorylation affects DNA repair.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40843-4

By:

Parisis, Nikolaos;
Dans, Pablo D.;
Jbara, Muhammad;
Singh, Balveer;
Schausi-Tiffoche, Diane;
Molina-Serrano, Diego;
Brun-Heath, Isabelle;
Hendrychová, Denisa;
Maity, Suman Kumar;
Buitrago, Diana;
Lema, Rafael;
Nait Achour, Thiziri;
Giunta, Simona;
Girardot, Michael;
Talarek, Nicolas;
Rofidal, Valérie;
Danezi, Katerina;
Coudreuse, Damien;
Prioleau, Marie-Noëlle;
Feil, Robert

Publication type:

Article

An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40578-2

By:

Igarashi, Taichi;
Mazevet, Marianne;
Yasuhara, Takaaki;
Yano, Kimiyoshi;
Mochizuki, Akifumi;
Nishino, Makoto;
Yoshida, Tatsuya;
Yoshida, Yukihiro;
Takamatsu, Nobuhiko;
Yoshimi, Akihide;
Shiraishi, Kouya;
Horinouchi, Hidehito;
Kohno, Takashi;
Hamamoto, Ryuji;
Adachi, Jun;
Zou, Lee;
Shiotani, Bunsyo

Publication type:

Article

Expression and prognostic significance of the P53‐related DNA damage repair proteins checkpoint kinase 1 (CHK1) and growth arrest and DNA‐damage‐inducible 45 alpha (GADD45A) in human oral squamous cell carcinoma.

Published in:

European Journal of Oral Sciences, 2020, v. 128, n. 2, p. 128, doi. 10.1111/eos.12685

By:

Xie, Liping;
Jia, Limin;
Qu, Jinyue;
Chen, Dong;
Lv, Yanhong;
Li, Haixia;
Zheng, Jinhua

Publication type:

Article

FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02630-3

By:

Pan, Yunzhi;
Liu, Jing;
Gao, Yingyin;
Guo, Yuqing;
Wang, Changxing;
Liang, Zhipan;
Wu, Meiying;
Qian, Yulan;
Li, Yinyan;
Shen, Jingyi;
Lu, Chenchen;
Ma, Sai

Publication type:

Article

The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.

Published in:

PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0302075

By:

Buchynska, Liubov;
Gordiienko, Inna;
Glushchenko, Nadiia;
Iurchenko, Nataliia

Publication type:

Article

Correction: ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation.

Published in:

2023

By:

Kolb, Ryan H.;
Greer, Patrick M.;
Cao, Phu T.;
Cowan, Kenneth H.;
Yan, Ying

Publication type:

Correction Notice

Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.

Published in:

Journal of Pathology, 2023, v. 259, n. 2, p. 194, doi. 10.1002/path.6032

By:

Sundararajan, Vignesh;
Tan, Tuan Zea;
Lim, Diana;
Peng, Yanfen;
Wengner, Antje Margret;
Ngoi, Natalie Yan Li;
Jeyasekharan, Anand D;
Tan, David Shao Peng

Publication type:

Article

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.

Published in:

Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01380-0

By:

Gu, Chunyan;
Wang, Wang;
Tang, Xiaozhu;
Xu, Tingting;
Zhang, Yanxin;
Guo, Mengjie;
Wei, Rongfang;
Wang, Yajun;
Jurczyszyn, Artur;
Janz, Siegfried;
Beksac, Meral;
Zhan, Fenghuang;
Seckinger, Anja;
Hose, Dirk;
Pan, Jingxuan;
Yang, Ye

Publication type:

Article

Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.

Published in:

Cancer Gene Therapy, 2014, v. 21, n. 5, p. 209, doi. 10.1038/cgt.2014.20

By:

Ye, F;
Yang, Z;
Liu, Y;
Gong, D;
Ji, T;
Wang, J;
Xi, B;
Zhou, J;
Ma, D;
Gao, Q

Publication type:

Article

Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells.

Published in:

Biological Chemistry, 2024, v. 405, n. 6, p. 395, doi. 10.1515/hsz-2023-0111

By:

Krkoška, Martin;
Paruch, Kamil;
Šošolíková, Tereza;
Vázquez-Gómez, Gerardo;
Herůdková, Jarmila;
Novotný, Jan;
Ovesná, Petra;
Sova, Petr;
Hyršlová Vaculová, Alena

Publication type:

Article

Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy.

Published in:

Molecules, 2022, v. 27, n. 15, p. 4736, doi. 10.3390/molecules27154736

By:

Nickoloff, Jac A.

Publication type:

Article

Benzothiazole and Chromone Derivatives as Potential ATR Kinase Inhibitors and Anticancer Agents.

Published in:

Molecules, 2022, v. 27, n. 14, p. N.PAG, doi. 10.3390/molecules27144637

By:

Frasinyuk, Mykhaylo;
Chhabria, Dimple;
Kartsev, Victor;
Dilip, Haritha;
Sirakanyan, Samvel N.;
Kirubakaran, Sivapriya;
Petrou, Anthi;
Geronikaki, Athina;
Spinelli, Domenico

Publication type:

Article

Vitamin-Containing Antioxidant Formulation Reduces Carcinogen-Induced DNA Damage through ATR/Chk1 Signaling in Bronchial Epithelial Cells In Vitro.

Published in:

Biomedicines, 2021, v. 9, n. 11, p. 1665, doi. 10.3390/biomedicines9111665

By:

Merlin, J.P. Jose;
Dellaire, Graham;
Murphy, Kieran;
Rupasinghe, H.P. Vasantha

Publication type:

Article

Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.68677

By:

Pereira, Catalina;
Arroyo-Martinez, Gerardo A.;
Guo, Matthew Z.;
Downey, Michael S.;
Kelly, Emma R.;
Grive, Kathryn J.;
Mahadevaiah, Shantha K.;
Sims, Jennie R.;
Faca, Vitor M.;
Tsai, Charlton;
Schiltz, Carl J.;
Wit, Niek;
Jacobs, Heinz;
Clark, Nathan L.;
Freire, Raimundo;
Turner, James;
Lyndaker, Amy M.;
Brieno-Enriquez, Miguel A.;
Cohen, Paula E.;
Smolka, Marcus B.

Publication type:

Article

Duox-generated reactive oxygen species activate ATR/Chk1 to induce G2 arrest in Drosophila tracheoblasts.

Published in:

eLife, 2021, p. 1, doi. 10.7554/eLife.68636

By:

Kizhedathu, Amrutha;
Chhajed, Piyush;
Yeramala, Lahari;
Basu, Deblina Sain;
Mukherjee, Tina;
Vinothkumar, Kutti R.;
Guha, Arjun

Publication type:

Article

Fms-like tyrosine kinase 3-internal tandem duplications epigenetically activates checkpoint kinase 1 in acute myeloid leukemia cells.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92566-5

By:

Zhang, Yudong;
Yuan, Lingli

Publication type:

Article

Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89684-5

By:

Isono, Makoto;
Okubo, Kazuki;
Asano, Takako;
Sato, Akinori

Publication type:

Article

Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86490-x

By:

Ditano, Jennifer P.;
Donahue, Katelyn L.;
Tafe, Laura J.;
McCleery, Charlotte F.;
Eastman, Alan

Publication type:

Article

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.929123

By:

Keller, Kaylee M.;
Eleveld, Thomas F.;
Schild, Linda;
den Handel, Kim van;
den Boogaard, Marlinde van;
Amo-Addae, Vicky;
Eising, Selma;
Ober, Kimberley;
Koopmans, Bianca;
Looijenga, Leendert;
Tytgat, Godelieve A. M.;
Ylstra, Bauke;
Molenaar, Jan J.;
Dolman, M. Emmy M.;
van Hooff, Sander R.

Publication type:

Article

Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1016683

By:

Ji Chen;
Mengjiao Sun;
Chuqin Chen;
Bin Jiang;
Yongjun Fang

Publication type:

Article

Synergistic targeting of CHK1 and mTOR in MYC-driven tumors.

Published in:

Carcinogenesis, 2021, v. 42, n. 3, p. 448, doi. 10.1093/carcin/bgaa119

By:

Song, Xiaoxue;
Wang, Liyuan;
Wang, Tianci;
Hu, Juncheng;
Wang, Jingchao;
Tu, Rongfu;
Su, Hexiu;
Jiang, Jue;
Qing, Guoliang;
Liu, Hudan

Publication type:

Article

Overexpression of CHK1 and CHK2 in pediatric patients of B -acute lymphoblastic leukemia.

Published in:

Iranian Journal of Pediatric Hematology & Oncology, 2023, v. 13, n. 4, p. 233, doi. 10.18502/ijpho.v13i4.13769

By:

Heidari, Farshad;
Faranoush, Mohammad;
Amini, Ali;
Rahimian, Elahe;
Kazemi, Kamyar;
Paridar, Mostafa;
Safa, Majid

Publication type:

Article

Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.

Published in:

International Journal of Radiation Biology, 2023, v. 99, n. 6, p. 941, doi. 10.1080/09553002.2021.1913529

By:

Hauge, Sissel;
Mariampillai, Adrian Eek;
Rødland, Gro Elise;
Bay, Lilli T. E.;
Landsverk, Helga B.;
Syljuåsen, Randi G.

Publication type:

Article

Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT-methylated glioblastoma.

Published in:

Science Translational Medicine, 2024, v. 16, n. 767, p. 1, doi. 10.1126/scitranslmed.ado1573

By:

Liao, Xinyi;
Zhang, Shuxia;
Li, Xincheng;
Qian, Wanying;
Li, Man;
Chen, Suwen;
Wu, Xingui;
Yu, Xuexin;
Li, Ziwen;
Tang, Miaoling;
Xu, Yingru;
Yu, Ruyuan;
Zhang, Qiliang;
Wu, Geyan;
Zhang, Nu;
Song, Libing;
Li, Jun

Publication type:

Article

Bioinformatics Analysis Reveals the Related Role of miR-511-5p in the Progression of Breast Cancer.

Published in:

Journal of Healthcare Engineering, 2022, p. 1, doi. 10.1155/2022/7146338

By:

Wang, Teng;
Liu, Jinquan;
Zhong, Rui;
Zhang, Yidan;
Sun, Zhenxuan;
Li, Jutao;
Hu, Gang;
Sun, Li;
Liu, Jintao

Publication type:

Article

Bioinformatics, Molecular Docking Simulation and in vitro Experiments Reveal the Bioactive Compounds and Mechanism of Coptis chinensis Franch. Against Colorectal Adenocarcinoma.

Published in:

Pharmacognosy Magazine, 2023, v. 19, n. 4, p. 967, doi. 10.1177/09731296231189553

By:

Liu, Xin;
Huang, Xu-ying;
Liu, Zhong;
Liu, Li;
Tu, Han

Publication type:

Article

Relative free-energy calculations for scaffold hopping-type transformations with an automated RE-EDS sampling procedure.

Published in:

Journal of Computer-Aided Molecular Design, 2022, v. 36, n. 2, p. 117, doi. 10.1007/s10822-021-00436-z

By:

Ries, Benjamin;
Normak, Karl;
Weiß, R. Gregor;
Rieder, Salomé;
Barros, Emília P.;
Champion, Candide;
König, Gerhard;
Riniker, Sereina

Publication type:

Article

Candida albicans CHK1 gene regulates its cross-kingdom interactions with Streptococcus mutans to promote caries.

Published in:

Applied Microbiology & Biotechnology, 2022, v. 106, n. 21, p. 7251, doi. 10.1007/s00253-022-12211-7

By:

Liu, Yaqi;
Wang, Zheng;
Zhou, Ziyi;
Ma, Qizhao;
Li, Jing;
Huang, Jun;
Lei, Lei;
Zhou, Xuedong;
Cheng, Lei;
Zou, Jing;
Ren, Biao

Publication type:

Article

Candida albicans CHK1 gene from two-component system is essential for its pathogenicity in oral candidiasis.

Published in:

Applied Microbiology & Biotechnology, 2021, v. 105, n. 6, p. 2485, doi. 10.1007/s00253-021-11187-0

By:

Zhou, Yujie;
Cheng, Lei;
Liao, Binyou;
Shi, Yangyang;
Niu, Yulong;
Zhu, Chengguang;
Ye, Xingchen;
Zhou, Xuedong;
Ren, Biao

Publication type:

Article

The cytosolic iron–sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors.

Published in:

NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00353-2

By:

Redwood, Abena B.;
Zhang, Xiaomei;
Seth, Sahil B.;
Ge, Zhongqi;
Bindeman, Wendy E.;
Zhou, Xinhui;
Sinha, Vidya C.;
Heffernan, Timothy P.;
Piwnica-Worms, Helen

Publication type:

Article

421 Specific cephalosporin antibiotics deplete tumor PD-L1 to inhibit DNA damage sensing and sensitize to Chk1 inhibitors in vivo.

Published in:

2022

By:

Murray, Clare;
Kornepati, Anand;
Padron, Alvaro;
Deng, Yilun;
Garcia, Myrna;
Bai, Haiyan;
Curiel, Tyler

Publication type:

Abstract

DNA Damage Response Signaling Cascade Regulates Proliferation of the Phytopathogenic Fungus Ustilago maydis in Planta.

Published in:

Plant Cell, 2011, v. 23, n. 4, p. 1654, doi. 10.1105/tpc.110.082552

By:

Sena-Tomás, Carmen de;
Fernández-Álvarez, Alfonso;
Holloman, William K.;
Pérez-Martín, José

Publication type:

Article

The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48076-9

By:

Prasad, Chandra Bhushan;
Oo, Adrian;
Liu, Yujie;
Qiu, Zhaojun;
Zhong, Yaogang;
Li, Na;
Singh, Deepika;
Xin, Xiwen;
Cho, Young-Jae;
Li, Zaibo;
Zhang, Xiaoli;
Yan, Chunhong;
Zheng, Qingfei;
Wang, Qi-En;
Guo, Deliang;
Kim, Baek;
Zhang, Junran

Publication type:

Article

Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02360-y

By:

Pescatori, Sara;
Leone, Stefano;
Cipolletti, Manuela;
Bartoloni, Stefania;
di Masi, Alessandra;
Acconcia, Filippo

Publication type:

Article

HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02258-9

By:

Citro, Simona;
Miccolo, Claudia;
Medda, Alessandro;
Ghiani, Lavinia;
Tagliabue, Marta;
Ansarin, Mohssen;
Chiocca, Susanna

Publication type:

Article

Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.

Published in:

Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00869-3

By:

Yu, Xinfang;
Li, Wei;
Liu, Haidan;
Deng, Qipan;
Wang, Xu;
Hu, Hui;
Xu-Monette, Zijun Y.;
Xiong, Wei;
Lu, Zhongxin;
Young, Ken H.;
Wang, Wei;
Li, Yong

Publication type:

Article

CHEK2 gene in breast cancer.

Published in:

Romanian Medical Journal, 2022, v. 69, n. 3, p. 15, doi. 10.37897/RMJ.2022.S3.4

By:

Maioru, Ovidiu;
Pop, Lucian;
Radoi, Viorica;
Ursu, Radu;
Bacalbasa, Nicolae;
Balescu, Irina;
Suciu, Ioan D.

Publication type:

Article

Identification of CHK1 Kinase Inhibitors Using Structure-Based Pharmacophore Modelling and Molecular Docking.

Published in:

Indian Journal of Pharmaceutical Sciences, 2020, v. 82, n. 3, p. 472, doi. 10.36468/pharmaceutical-sciences.670

By:

AL-SHAR'I, N. A.;
MUSLEH, SONDOS

Publication type:

Article

Identification of formononetin as the active compound of CR‐SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co‐expression networks.

Published in:

Chemical Biology & Drug Design, 2024, v. 103, n. 1, p. 1, doi. 10.1111/cbdd.14363

By:

Li, Chun;
Xie, Yuxin;
Hu, Shaoyu;
Yu, Hong;
Xu, Yunke;
Shen, Hongping;
Yuan, Yuan;
Gu, Long;
Pu, Bangming

Publication type:

Article

Anticancer potentiating effect and downregulation of PD‐L1 expression: Study on the 2‐[(p‐fluorophenyl)amino]‐6‐substituted‐9H‐purine analogues as novel CHK1 inhibitors.

Published in:

Chemical Biology & Drug Design, 2023, v. 101, n. 3, p. 626, doi. 10.1111/cbdd.14156

By:

Chen, Xuanzhen;
Wang, Meng;
Wang, Xiaowei;
Liu, Junyi;
Zhang, Zhili;
Tian, Chao

Publication type:

Article

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions.

Published in:

Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04338-6

By:

Zhang, Chenyue;
Zhang, Chenxing;
Wang, Kai;
Wang, Haiyong

Publication type:

Article